Jaw Neoplasms

Cancers or tumors of the MAXILLA or MANDIBLE unspecified. For neoplasms of the maxilla, MAXILLARY NEOPLASMS is available and of the mandible, MANDIBULAR NEOPLASMS is available.

Also Known As:

Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Hypercalcemia (Milk Alkali Syndrome)
2.	Neoplasms (Cancer)
3.	Leukocytosis (Pleocytosis)
4.	Squamous Cell Carcinoma (Epidermoid Carcinoma)
5.	Bone Resorption

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Jaw Neoplasms:

1.	Alendronate (Alendronate Sodium)FDA LinkGeneric 09/01/1994 - "The inhibitory effect of murine interferon gamma (muIFN gamma) on humoral hypercalcemia in nude mice bearing lower-jaw cancer (LJC-1-JCK), in which parathyroid-hormone(PTH)-related protein is responsible for causing humoral hypercalcemia by activating bone resorption, was examined in comparison with that of a new bisphosphonate, 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (alendronate). "
2.	PlasticsIBA 03/16/1973 - "[Surgical management of jaw neoplasms and neoplasms of surrounding soft tissue including plastic and reconstructive measures. "
3.	Parathyroid Hormone (Parathormone)IBA 09/01/1994 - "The inhibitory effect of murine interferon gamma (muIFN gamma) on humoral hypercalcemia in nude mice bearing lower-jaw cancer (LJC-1-JCK), in which parathyroid-hormone(PTH)-related protein is responsible for causing humoral hypercalcemia by activating bone resorption, was examined in comparison with that of a new bisphosphonate, 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (alendronate). "
4.	Interferon-gamma (Interferon, gamma)IBA 09/01/1994 - "The inhibitory effect of murine interferon gamma (muIFN gamma) on humoral hypercalcemia in nude mice bearing lower-jaw cancer (LJC-1-JCK), in which parathyroid-hormone(PTH)-related protein is responsible for causing humoral hypercalcemia by activating bone resorption, was examined in comparison with that of a new bisphosphonate, 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (alendronate). "
5.	Glutathione (Reduced Glutathione)IBA 04/01/1977 - "[Changes in the activity of glucose-6-phosphate dehydrogenase and the content of reduced glutathione in erythrocytes of patients with jaw neoplasms]."
6.	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 04/01/1977 - "[Changes in the activity of glucose-6-phosphate dehydrogenase and the content of reduced glutathione in erythrocytes of patients with jaw neoplasms]."
7.	bone resorption factorIBA 09/01/1989 - "Previously we reported that a clonal squamous cell carcinoma cell line (T3M-1) derived from a lower jaw cancer of a patient with marked leukocytosis and hypercalcemia produced factors containing a potent bone-resorbing activity (BRA) (Mr 15,000-20,000) and a colony-stimulating activity. "

Therapies and Procedures

1.	X-Ray Therapy 10/01/1971 - "[Roentgenotherapy in treatment of cancer of the jaw]."
2.	Intratracheal Anesthesia 05/01/1969 - "[Intratracheal anesthesia in operations of jaw neoplasms]."